|
Information provided by Petersons.com | |
arable |
|
|
|
JESSICA'S DIVA DEMANDS
Jessica Simpson, 25, likes to act clueless, but she can swing her celebrity weight like a pro. According to a studio source, weeks before the press tour for The Dukes of Hazzard began, "we were bombarded with a six-page pamphlet of demands for Jessica from the office of her dad, Joe Simpson." Among Jessica's requests: paid accommodations for her hairstylist and assistant in the same hotel as Jessica; a wardrobe budget estimated in the thousands of dollars; cases of Evian water; and paid private...
JEN FREAKS OVER ANGELINA'S NEW BABY JULIA STILES, GWYNETH PALTROW AND MORE!
| |
DIA | Jul 4 3:44pm PT |
|
QQQQ | Sep 20 7:02am PT |
|
SPY | Sep 20 5:50am PT |
|
Currency | U.S. Dollar (USD) | Euro (EUR) | Canadian Dollar (CAD) | Japanese Yen (JPY) | Australian Dollar (AUD) | USD | 1 | 1.214000 | 0.855725 | 0.00894534 | 0.767600 | EUR | 0.823452 | 1 | 0.704648 | 0.00736606 | 0.632082 | CAD | 1.168000 | 1.417952 | 1 | 0.0104482 | 0.896557 | JPY | 111.7400 | 135.6524 | 95.61869 | 1 | 85.77161 | AUD | 1.301914 | 1.580524 | 1.114080 | 0.0116461 | 1 |
|
1:17 pm PT Oakley names Scott Olivet as CEOþOO 17.36 -0.42:Co appoints Scott Olivet as C.E.O. succeeding Oakley founder, Chairman and C.E.O. Jim Jannard who will continue as chairman of the board of directors. Jannard says "As our business continues to grow and gets more complex, it's apparent that my main passion lies in the chief mad scientist role. I am an inventor and entrepreneur at heart; I love electron beam gun vapor deposition machines and liquid laser prototypes - I see visions of the future when I sleep, not spreadsheets." Since 2001, Mr. Olivet, 43, served as a VP at Nike.
| 1:06 pm PT Elan and Biogen Idec Provide an Update on TYSABRIþELN 8.31 +0.14:ELN and BIIB announced that in the coming weeks they expect the safety evaluation of Tysabri in Crohn's disease and rheumatoid arthritis will be completed, and that they will submit a supplemental Biologics License Application for Tysabri in multiple sclerosis to the FDA.
| 1:04 pm PT Christopher & Banks reports $0.01 below consensusþCBK :Reports Q2 (Aug) earnings of $0.16 per share, $0.01 worse than the Reuters Estimates consensus of $0.17; revenues rose 15.0% year/year to $110.8 mln vs the $112.4 mln consensus. Co issues in-line guidance for FY06, sees EPS of $0.78-0.83 vs. $0.83 consensus. For the second half of the year, co expects earnings to be $0.37-0.42.
| Information provided by Briefing.com | More |
|
___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ | |